...
首页> 外文期刊>Journal of Applied Biomedicine >?2-Cyclodextrin modified mesoporous silica nanoparticles as a nano-carrier: Response surface methodology to investigate and optimize loading and release processes for curcumin delivery
【24h】

?2-Cyclodextrin modified mesoporous silica nanoparticles as a nano-carrier: Response surface methodology to investigate and optimize loading and release processes for curcumin delivery

机译:α2-环糊精修饰的介孔二氧化硅纳米颗粒作为纳米载体:响应面方法,用于研究和优化姜黄素递送的加载和释放过程

获取原文
           

摘要

?2-Cyclodextrin functionalized PEGylated porous silica nanoparticles KIT-6 (denoted as [?2-CD@PEGylated KIT-6] NPs) is synthesized and evaluated as an efficient and reliable pH-sensitive nano-carrier. Curcumin (CUR), an anticancer drug, has low solubility and stability and these properties diminished its bioavailability. One way to overcome this problem is employing nano-carrier for delivery of CUR. In this study, the novel [?2-CD@PEGylated KIT-6] NPs nano-carrier was employed for CUR delivery successfully. The nano-DDS was characterized using different techniques such as X-ray powder diffraction (XRD), transmission and scanning electron microscopy (TEM and SEM), Fourier transform infrared (FT-IR) spectroscopy, differential scanning calorimeter (DSC), N2 adsorptiona??desorption measurement, and dynamic light scattering (DLS). In this study, first, the combination of central composite design (CCD) and response surface methodology (RSM) was used to achieve the optimal condition of the loading step with investigation of two important factors: the loading time and the weight ratio of drug to nano-carrier. Maximum loading efficiency 88.55% was obtained at 43??h of loading time and 1.22 of the weight ratio. Then CUR was loaded onto the nano-carrier at this optimal condition and its released was investigated by CCD-RSM. The maximum drug release was obtained at 5.16 of pH and 107??h of release time.
机译:合成了β2-环糊精官能化的聚乙二醇化多孔二氧化硅纳米粒子KIT-6(表示为[β2-CD@聚乙二醇化的KIT-6]纳米粒子),并将其评估为有效且可靠的pH敏感纳米载体。姜黄素(CUR)是一种抗癌药物,具有低溶解度和稳定性,并且这些特性会降低其生物利用度。克服此问题的一种方法是采用纳米载体递送CUR。在这项研究中,新型的[α2-CD@ PEG化的KIT-6] NPs纳米载体被成功地用于CUR递送。使用不同的技术对纳米DDS进行表征,例如X射线粉末衍射(XRD),透射和扫描电子显微镜(TEM和SEM),傅立叶变换红外(FT-IR)光谱,差示扫描量热仪(DSC),N2吸附解吸测量,以及动态光散射(DLS)。在这项研究中,首先,通过研究两个重要因素:药物的加载时间和药物与药物的重量比,将中心复合设计(CCD)和响应表面方法(RSM)的组合用于实现加载步骤的最佳条件。纳米载体。在装载时间为43 ?? h和重量比为1.22时,可获得最大装载效率88.55%。然后在此最佳条件下将CUR加载到纳米载体上,并通过CCD-RSM研究其释放。在5.16的pH和107?h的释放时间下可获得最大的药物释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号